34th annual EMSOS congress. Ewing's sarcoma
As part of EMSOS-2022, a separate section is devoted to Ewing's sarcoma- one of the most aggressive bone tumors, most often affecting children and young people. Leading experts in this field of oncoorthopedics discussed highly specialized issues within the current challenges in local treatment and future perspectives. The following reports deserve attention:
- "Upcoming international Ewing sarcoma trials - an update Inter-Ewing-1" Dr JHM Merks, Princess Máxima Center for Pediatric Oncology, Netherlands iEuroEwing. Professor Uta Dirksen, University Hospital Essen, Germany
- Interactive MDT – how would you locally treat these challenging cases? » Discussion of 3-4 cases in an MDT format, short presentation of available evidence, followed by public voting
Follow the news on medpresso.org